Clinical trial
Carbonic Anhydrase IX-targeted PET/CT Imaging for Detecting Solid Tumors
NCT07833085 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carbonic Anhydrase IX-targeted PET/CT Imaging for Detecting Solid Tumors
- Lead sponsor
- Zhongnan Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 21, 2026
- Completion date
- December 31, 2031
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, clear cell renal cell carcinoma, lung cancer (nsclc), malignant solid tumors